Association of promoter polymorphisms in MMP2 and TIMP2 with prostate cancer susceptibility in North India.

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Archives of Medical Research

• Publication date

  2012-02-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.arcmed.2012.02.006PMID 22374248
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• An immunohistochemical study

  2013cited by this paper
• Global cancer statistics

  2011cited by this paper
• Role of MMP-3 and MMP-9 and Their Haplotypes in Risk of Bladder Cancer in North Indian Cohort

  2010cited by this paper
• Matrix metalloproteinase-2 polymorphism is associated with prognosis in prostate cancer.

  2010cited by this paper
• Bladder Cancer Risk Associated with Genotypic Polymorphism of the Matrix Metalloproteinase-1 and 7 in North Indian Population

  2010cited by this paper
• Association of functional polymorphisms in MMPs genes with gastric cardia adenocarcinoma and esophageal squamous cell carcinoma in high incidence region of North China

  2009cited by this paper
• Tissue inhibitor of metalloproteinase-2 G-418C polymorphism is associated with an increased risk of gastric cancer in a Chinese population.

  2008cited by this paper
• Strong association of the tissue inhibitor of metalloproteinase-2 polymorphism with an increased risk of oral squamous cell carcinoma in Europeans.

  2007cited by this paper
• Functional polymorphisms in the promoter regions of MMP2 and MMP3 are not associated with melanoma progression

  2007cited by this paper
• Detection of polymorphisms in the promoters of matrix metalloproteinases 2 and 9 genes in breast cancer in South Brazil: preliminary results

  2007cited by this paper
• Matrix Metalloproteinase-2 Promoter Polymorphism Is Associated with Breast Cancer in a Mexican Population

  2007cited by this paper
• Genotypes and haplotypes of matrix metalloproteinase 1, 3 and 12 genes and the risk of lung cancer.

  2006cited by this paper
• The role of genetic polymorphisms in the promoters of the matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 genes in head and neck cancer.

  2006cited by this paper
• Clinical impact of MMP and TIMP gene polymorphisms in gastric cancer

  2006cited by this paper
• Matrix metalloproteinase (MMP) -1, -2, -3 and -9 promoter polymorphisms in colorectal cancer.

  2006cited by this paper
• Global Cancer Statistics, 2002

  2005cited by this paper
• The functional polymorphism in the matrix metalloproteinase-7 promoter increases susceptibility to esophageal squamous cell carcinoma, gastric cardiac adenocarcinoma and non-small cell lung carcinoma.

  2005cited by this paper
• Angiogenesis and prostate cancer tumor growth

  2004cited by this paper
• Expression of Tissue Inhibitors of Metalloproteinases (TIMPs) in Gastric Cancer

  2004cited by this paper
• Genetic polymorphisms in the MMP-2 and MMP-9 genes and breast cancer phenotype

  2004cited by this paper
• Functional Haplotypes in the Promoter of Matrix Metalloproteinase-2 Predict Risk of the Occurrence and Metastasis of Esophageal Cancer

  2004cited by this paper
• Prognostic Significance of Matrix Metalloproteinase 2 and Tissue Inhibitor of Metalloproteinase 2 Expression in Prostate Cancer

  2003cited by this paper
• Substantial reduction in risk of breast cancer associated with genetic polymorphisms in the promoters of the matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 genes.

  2003cited by this paper
• Tissue Inhibitor of Metalloproteinases-1, −2, and −3 Polymorphisms in a White Population With Intracranial Aneurysms

  2003cited by this paper
• Two MMP-2 Promoter Polymorphisms (–790T/G and –735C/T) in Chronic Heart Failure

  2003cited by this paper
• Roles of matrix metalloproteinases in tumor metastasis and angiogenesis.

  2003cited by this paper
• The role of angiogenesis in prostate development and the pathogenesis of prostate cancer

  2002cited by this paper
• A single nucleotide polymorphism in the matrix metalloproteinase-3 promoter enhances breast cancer susceptibility.

  2002cited by this paper
• Identification of Novel, Functional Genetic Variants in the Human Matrix Metalloproteinase-2 Gene

  2001cited by this paper
• Down-regulation of vascular endothelial growth factor by tissue inhibitor of metalloproteinase-2: effect on in vivo mammary tumor growth and angiogenesis.

  2001cited by this paper
• Tissue inhibitor of metalloproteinases-2 gene polymorphisms in chronic obstructive pulmonary disease.

  2001cited by this paper
• Expression of membrane-type 1 matrix metalloproteinase (MT1-MMP) on prostate cancer cell lines.

  2000cited by this paper
• Synthetic inhibitor of matrix metalloproteases decreases tumor growth and metastases in a syngeneic model of rat prostate cancer in vivo

  2000cited by this paper
• TIMP-2 Is Required for Efficient Activation of proMMP-2 in Vivo *

  2000cited by this paper
• Environmental and heritable factors in the causation of cancer--analyses of cohorts of twins from Sweden, Denmark, and Finland.

  2000cited by this paper
• Dietary fat and prostate cancer: current status.

  1999cited by this paper
• Expression of tissue inhibitor of metalloproteinases TIMP-2 in human colorectal cancer--a predictor of tumour stage.

  1997cited by this paper
• Characterization of the promoter of the gene encoding human tissue inhibitor of metalloproteinases-2 (TIMP-2).

  1994cited by this paper
• A simple salting out procedure for extracting DNA from human nucleated cells.

  1988cited by this paper
• Prediction of prognosis for prostatic adenocarcinoma by combined histological grading and clinical staging.

  1974cited by this paper

• Integrated analysis of transcriptomics and proteomics hinted that PI3k-Akt and TGF-beta signaling pathways may synergistically regulate calipash development of Chinese Soft-Shell turtle at embryonic stage.

  2025cites this paper
• Insights from Tissue Inhibitor of Metalloproteinase-2 Genotypes to Decipher the Genetic Architecture of Childhood Acute Lymphocytic Leukemia Risk

  2025cites this paper
• Functional relevance of MMP2 promoter variants in gallbladder cancer: A case-control study in an Eastern Indian Population.

  2024cites this paper
• Matrix metalloproteinases targeting in prostate cancer.

  2024cites this paper
• Targeting Matrix Metalloproteinases and Their Inhibitors in Melanoma

  2024cites this paper
• Current evidence on the relationships among five polymorphisms in the matrix metalloproteinases genes and prostate cancer risk

  2024cites this paper
• Association of TIMP2 418 G/C and MMP Gene Polymorphism with Risk of Urinary Cancers: Systematic Review and Meta-analysis

  2024cites this paper
• The Potential of Extracellular Matrix- and Integrin Adhesion Complex-Related Molecules for Prostate Cancer Biomarker Discovery

  2023cites this paper
• The Contribution of Tissue Inhibitor of Metalloproteinase-2 Genotypes to Breast Cancer Risk in Taiwan

  2023cites this paper
• Single Nucleotide Polymorphisms in MMPGenes and Susceptibility to Growth, Invasion, Progression, and Metastasis of Cancer

  2022cites this paper
• OTX1 promotes tumorigenesis and progression of cervical cancer by regulating the Wnt signaling pathway

  2022cites this paper
• Identification of TIMP2 as a Prognostic Biomarker and Its Correlation with Tumor Immune Microenvironment: A Comprehensive Pan-Cancer Analysis

  2022cites this paper
• of Oncology Research Impacts of Genetic Polymorphisms on Breast Cancer

  2022cites this paper
• A Comprehensive Bioinformatics Analysis of TIMP2 in Multiple Malignancies

  2021cites this paper
• The Role of the Metzincin Superfamily in Prostate Cancer Progression: A Systematic-Like Review

  2021cites this paper
• Activities and polymorphisms of MMP-2 and MMP-9, smoking, diabetes and risk of prostate cancer

  2020cites this paper
• Investigation of MMP-9 rs3918242 and TIMP-2 rs8179090 polymorphisms in renal cell carcinoma tissues

  2020cites this paper
• Data-mining approach for screening of rare genetic elements associated with predisposition of prostate cancer in South-Asian populations

  2019cites this paper
• Genetic polymorphisms associated with the prevalence of retinal vein occlusion in a Greek population

  2019cites this paper
• Association between TIMP-2 gene polymorphism and breast cancer in Han Chinese women

  2019cites this paper
• Strong association of tissue inhibitor of metalloproteinase (TIMP)-2 and -3 promoter single nucleotide polymorphisms with risk of colorectal cancer in ethnic Kashmiri population – a case control study

  2019cites this paper
• Tissue Inhibitor of Metalloproteinase-2 Polymorphisms and Risk for HIV-Associated Neurocognitive Disorder

  2019influential citation
• Glucose Transporter 1 Promotes the Malignant Phenotype of Non-Small Cell Lung Cancer through Integrin β1/Src/FAK Signaling

  2019cites this paper
• Polymorphism in dural arteriovenous fistula: matrix metalloproteinase‐2‐1306 C/T as a potential risk factor for sinus thrombosis

  2018cites this paper
• Association between matrix-metalloproteinase polymorphisms and prostate cancer risk: a meta-analysis and systematic review

  2018cites this paper
• Gene Polymormisms and Prostate Cancer: A Systematic Review

  2018cites this paper
• Association of zinc level and polymorphism in MMP-7 gene with prostate cancer in Polish population

  2018cites this paper
• The association between MMP2 −1306 C > T (rs243865) polymorphism and risk of prostate cancer

  2017cites this paper
• The MMP2 rs243865 polymorphism increases the risk of prostate cancer: A meta-analysis

  2017cites this paper
• The extract from Punica granatum (pomegranate) peel induces apoptosis and impairs metastasis in prostate cancer cells.

  2017cites this paper
• rs3918242 variant genotype frequency and increased TIMP-2 and MMP-9 expression are positively correlated with cancer invasion in urinary bladder cancer.

  2017cites this paper
• Association between MMP2-1306 C/T polymorphism and prostate cancer susceptibility: a meta-analysis based on 3906 subjects

  2017cites this paper
• Single nucleotide polymorphisms in an Indian cohort and association of CNTN4, MMP2 and SNTB1 variants with oral cancer.

  2017cites this paper
• Genetic Association between Matrix Metalloproteinases Gene Polymorphisms and Risk of Prostate Cancer: A Meta-Analysis

  2017influential citation
• The MMP-2 and MMP-9 promoter polymorphisms and susceptibility to salivary gland cancer.

  2016cites this paper
• Clinicopathologic and Prognostic Significance of Metalloproteinase Tissue Inhibitor-2 Promoters in Tunisian Colorectal Cancer: A Case-Control Study

  2016cites this paper
• Matrix metalloproteinase (MMP) -2, -7 and -9 promoter polymorphisms in colorectal cancer in ethnic Kashmiri population - A case-control study and a mini review.

  2016cites this paper
• Genetic Association Studies on Prostate Cancer

  2016cites this paper
• Analysis of MMP2-1306C/T and TIMP2G-418C polymorphisms with relapsing remitting multiple sclerosis

  2016cites this paper
• Association between MMP-2 expression and prostate cancer: A meta-analysis.

  2016cites this paper
• Role of MMP-2 (-1306 C/T) Polymorphism in Pituitary Adenoma

  2016cites this paper
• The protective role of the −1306C>T functional polymorphism in matrix metalloproteinase-2 gene is associated with cervical cancer: implication of human papillomavirus infection

  2016cites this paper
• Matrix metalloproteinase-2 -1306 C>T gene polymorphism is associated with reduced risk of cancer: a meta-analysis.

  2015cites this paper
• Genetic Polymorphism of MMP2 Gene and Susceptibility to Prostate Cancer.

  2015cites this paper
• TIMP-2 G-418C polymorphism and cancer risk: A meta-analysis.

  2015cites this paper
• Meta-analysis of association of the matrix metalloproteinase 2 (-735 C/T) polymorphism with cancer risk.

  2015cites this paper
• No Correlation between TIMP2 -418 G>C Polymorphism and Increased Risk of Cancer: Evidence from a Meta-Analysis

  2014cites this paper
• Polymorphisms in MMP-2 and TIMP-2 in Turkish patients with prostate cancer.

  2014cites this paper
• Normalization of the tumor microenvironment: evidence for tissue inhibitor of metalloproteinase-2 as a cancer therapeutic

  2014cites this paper
• Deriving a Mutation Index of Carcinogenicity Using Protein Structure and Protein Interfaces

  2014cites this paper
• Association of MMP2-1306C/T and TIMP2G-418C polymorphisms in retinal vein occlusion.

  2013cites this paper
• Effects of Musca domestica cecropin on the adhesion and migration of human hepatocellular carcinoma BEL-7402 cells.

  2013cites this paper
• Matrix metalloproteinase-2 C(-1306)T promoter polymorphism and breast cancer risk in the Saudi population.

  2013cites this paper
• Matrix metalloproteinase-2 (-1306 c>t) promoter polymorphism and risk of colorectal cancer in the Saudi population.

  2013cites this paper
• Polymorphisms in the promoters of MMP-2 and TIMP-2 genes in patients with acne vulgaris.

  2013cites this paper
• Original Article Polymorphisms in the promoters of MMP-2 and TIMP-2 genes in patients with acne vulgaris

  2013cites this paper
• Vaginal approaches to pelvic organ prolapse repair

  2013cites this paper
• The roles of beta-adrenergic receptors in tumorigenesis and the possible use of beta-adrenergic blockers for cancer treatment: possible genetic and cell-signaling mechanisms

  2012cites this paper
• The Impact of Vitamin D in Cancer

  2012cites this paper
• The roles of beta-adrenergic receptors in tumorigenesis and the possible use of beta-adrenergic blockers for cancer treatment: possible genetic and cell-signaling mechanisms

  2012cites this paper